Williams Jones Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.64M Buy
165,407
+3,158
+2% +$84.1K 0.06% 138
2025
Q4
$4.04M Sell
162,249
-7,816
-5% -$197K 0.05% 147
2025
Q3
$4.33M Sell
170,065
-2,650
-2% -$65.4K 0.05% 144
2025
Q2
$4.19M Sell
172,715
-11,518
-6% -$269K 0.05% 145
2025
Q1
$4.67M Sell
184,233
-1,549
-0.8% -$40.5K 0.06% 134
2024
Q4
$4.93M Sell
185,782
-14,646
-7% -$397K 0.06% 136
2024
Q3
$5.8M Sell
200,428
-6,272
-3% -$183K 0.07% 131
2024
Q2
$5.78M Sell
206,700
-6,848
-3% -$189K 0.07% 129
2024
Q1
$5.93M Sell
213,548
-18,532
-8% -$514K 0.08% 123
2023
Q4
$6.68M Sell
232,080
-43,133
-16% -$1.3M 0.09% 121
2023
Q3
$9.13M Sell
275,213
-16,101
-6% -$569K 0.14% 103
2023
Q2
$10.7M Sell
291,314
-34,118
-10% -$1.33M 0.16% 98
2023
Q1
$13.3M Sell
325,432
-3,501
-1% -$151K 0.21% 88
2022
Q4
$16.9M Sell
328,933
-23,574
-7% -$1.13M 0.28% 70
2022
Q3
$15.4M Buy
352,507
+11,416
+3% +$555K 0.27% 71
2022
Q2
$17.9M Buy
341,091
+99,832
+41% +$5.09M 0.29% 68
2022
Q1
$12.5M Buy
241,259
+74,787
+45% +$3.88M 0.17% 92
2021
Q4
$9.83M Buy
166,472
+9,607
+6% +$476K 0.12% 102
2021
Q3
$6.75M Buy
156,865
+62,891
+67% +$2.79M 0.09% 123
2021
Q2
$3.68M Sell
93,974
-2,224
-2% -$86.5K 0.05% 160
2021
Q1
$3.48M Sell
96,198
-11,264
-10% -$400K 0.05% 159
2020
Q4
$3.96M Sell
107,462
-12,469
-10% -$457K 0.06% 145
2020
Q3
$4.18M Buy
119,931
+432
+0.4% +$15.1K 0.08% 128
2020
Q2
$3.71M Buy
119,499
+2,991
+3% +$102K 0.08% 123
2020
Q1
$3.61M Buy
116,508
+8,684
+8% +$296K 0.09% 107
2019
Q4
$4.01M Sell
107,824
-14,612
-12% -$520K 0.08% 130
2019
Q3
$4.17M Buy
+122,436
New +$4.45M 0.09% 126

Other funds holding PFE

Williams Jones Wealth Management's PFE Position: Q1 2026 in Review

Williams Jones Wealth Management increased its Pfizer (PFE) stake by 1.9% in Q1 2026, buying an estimated $84.1K and bringing the position to 165,407 shares worth $4.64M. The position accounts for 0.06% of the portfolio, ranked #138.

Williams Jones Wealth Management first reported a position in PFE in Q3 2019 and has held it in 27 quarters since. The position peaked at $17.9M in Q2 2022. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Williams Jones Wealth Management held 165,407 shares of Pfizer worth $4.64M as of Q1 2026.
  • Williams Jones Wealth Management bought 3,158 Pfizer shares in Q1 2026, an estimated $84.1K.
  • Pfizer made up 0.06% of Williams Jones Wealth Management's portfolio in Q1 2026, its #138 holding.
  • Williams Jones Wealth Management first reported a position in Pfizer in Q3 2019 and has held it in 27 quarters since.
  • Williams Jones Wealth Management's Pfizer position peaked at $17.9M in Q2 2022.
  • 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Williams Jones Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.